Evidence map›Paper›PMID 32194405›Full record

ArticleFrontiers in pharmacology2020

Evaluating the Endocytosis and Lineage-Specification Properties of Mesenchymal Stem Cell Derived Extracellular Vesicles for Targeted Therapeutic Applications.

Chun-Chieh Huang, Miya Kang, Raghuvaran Narayanan, Luisa A DiPietro, Lyndon F Cooper, Praveen Gajendrareddy, Sriram Ravindran

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Functionality of lyophilized osteoinductive EVs: a mechanistic study.Frontiers in bioengineering and biotechnology · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Exosomes: A Tool for Bone Tissue Engineering.Tissue engineering. Part B, Reviews · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chun-Chieh HuangDepartment of Oral Biology, College of Dentistry, University of Illinois at Chicago, Chicago, IL, United States.
Miya KangDepartment of Oral Biology, College of Dentistry, University of Illinois at Chicago, Chicago, IL, United States.
Raghuvaran NarayananDepartment of Oral Biology, College of Dentistry, University of Illinois at Chicago, Chicago, IL, United States.
Luisa A DiPietroDepartment of Periodontics, College of Dentistry, University of Illinois at Chicago, Chicago, IL, United States.
Lyndon F CooperDepartment of Oral Biology, College of Dentistry, University of Illinois at Chicago, Chicago, IL, United States.
Praveen GajendrareddyDepartment of Periodontics, College of Dentistry, University of Illinois at Chicago, Chicago, IL, United States.
Sriram RavindranDepartment of Oral Biology, College of Dentistry, University of Illinois at Chicago, Chicago, IL, United States.
University of Illinois Chicago · US

Funding

Functional Activation and Targeting of Exosomes for Regenerative MedicineR01DE027404 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GAJENDRAREDDY, PRAVEEN, RAVINDRAN, SRIRAM · 2018 to 2022
$2.1M
NIDCR NIH HHS R01 DE027404
6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) are multipotent cells with regenerative and immunomodulatory properties. Several aspects of MSC function have been attributed to the paracrine effects of MSC derived extracellular vesicles (EVs). Although MSC EVs show great promise for regenerative medicine applications, insights into their uptake mechanisms by different target cells and the ability to control MSC EV properties for defined function

Indexed as

differentiationendocytosisexosomeextracellular vesiclesmesenchymal stem cells

Identifiers

PMID32194405
PMCPMC7063066
OpenAlexW3009998305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.